Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth.

Mihailovich M, Bremang M, Spadotto V, Musiani D, Vitale E, Varano G, Zambelli F, Mancuso FM, Cairns DA, Pavesi G, Casola S, Bonaldi T.

Nat Commun. 2015 Nov 10;6:8725. doi: 10.1038/ncomms9725.

2.

Hepatitis C virus upregulates B-cell receptor signaling: a novel mechanism for HCV-associated B-cell lymphoproliferative disorders.

Dai B, Chen AY, Corkum CP, Peroutka RJ, Landon A, Houng S, Muniandy PA, Zhang Y, Lehrmann E, Mazan-Mamczarz K, Steinhardt J, Shlyak M, Chen QC, Becker KG, Livak F, Michalak TI, Talwani R, Gartenhaus RB.

Oncogene. 2016 Jun 9;35(23):2979-90. doi: 10.1038/onc.2015.364. Epub 2015 Oct 5.

3.

Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.

Frau M, Feo F, Pascale RM.

J Hepatol. 2013 Oct;59(4):830-41. doi: 10.1016/j.jhep.2013.04.031. Epub 2013 May 7. Review.

4.

Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo.

Leucci E, Zriwil A, Gregersen LH, Jensen KT, Obad S, Bellan C, Leoncini L, Kauppinen S, Lund AH.

Oncogene. 2012 Dec 6;31(49):5081-9. doi: 10.1038/onc.2012.15. Epub 2012 Feb 6.

PMID:
22310293
5.

AU-rich RNA binding proteins in hematopoiesis and leukemogenesis.

Baou M, Norton JD, Murphy JJ.

Blood. 2011 Nov 24;118(22):5732-40. doi: 10.1182/blood-2011-07-347237. Epub 2011 Sep 13.

6.

HuR-mediated control of C/EBPbeta mRNA stability and translation in ALK-positive anaplastic large cell lymphomas.

Bergalet J, Fawal M, Lopez C, Desjobert C, Lamant L, Delsol G, Morello D, Espinos E.

Mol Cancer Res. 2011 Apr;9(4):485-96. doi: 10.1158/1541-7786.MCR-10-0351. Epub 2011 Feb 22.

7.

Novel mRNA-containing cytoplasmic granules in ALK-transformed cells.

Fawal M, Jean-Jean O, Vanzo N, Morello D.

Mol Biol Cell. 2011 Mar 15;22(6):726-35. doi: 10.1091/mbc.E10-07-0569. Epub 2011 Jan 13.

8.

ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes.

Mazan-Mamczarz K, Hagner PR, Zhang Y, Dai B, Lehrmann E, Becker KG, Keene JD, Gorospe M, Liu Z, Gartenhaus RB.

Blood. 2011 Feb 24;117(8):2441-50. doi: 10.1182/blood-2010-09-310987. Epub 2011 Jan 5.

9.

B cell lymphoma (Bcl)-2 protein is the major determinant in bcl-2 adenine-uridine-rich element turnover overcoming HuR activity.

Ghisolfi L, Calastretti A, Franzi S, Canti G, Donnini M, Capaccioli S, Nicolin A, Bevilacqua A.

J Biol Chem. 2009 Jul 31;284(31):20946-55. doi: 10.1074/jbc.M109.023721. Epub 2009 Jun 11.

10.

PMA induces stabilization of oncostatin M mRNA in human lymphoma U937 cells.

Bandyopadhyay S, Sengupta TK, Spicer EK.

Biochem J. 2008 Feb 15;410(1):177-86.

PMID:
17924856

Supplemental Content

Loading ...
Support Center